Appropriate use of tocilizumab in COVID-19 infection

OBJECTIVE: This study aimed to describe the effectiveness and optimum use of tocilizumab (TCZ) treatment by the support of clinical, laboratory and radiologic observations. METHODS: All patients were followed up in the hospital with daily interleukin-6 (IL-6), C-reactive protein (CRP), ferritin, d-d...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Infect Dis
Päätekijät: Keske, Şiran, Tekin, Süda, Sait, Bilgin, İrkören, Pelin, Kapmaz, Mahir, Çimen, Cansu, Uğur, Semra, Çelebi, İrfan, Bakır, Veli Oğuzalp, Palaoğlu, Erhan, Şentürk, Evren, Çağlayan, Benan, Çakar, Nahit, Tabak, Levent, Ergönül, Önder
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7382959/
https://ncbi.nlm.nih.gov/pubmed/32726724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.07.036
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia